TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 394 filers reported holding TANDEM DIABETES CARE INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,901,000 | -73.1% | 133,481 | -47.2% | 0.01% | -66.7% |
| Q1 2022 | $29,407,000 | -2.4% | 252,873 | +26.4% | 0.03% | +3.4% |
| Q4 2021 | $30,115,000 | +931.7% | 200,075 | +718.2% | 0.03% | +866.7% |
| Q3 2021 | $2,919,000 | +137.1% | 24,452 | +75.3% | 0.00% | +200.0% |
| Q1 2021 | $1,231,000 | -94.3% | 13,950 | -93.8% | 0.00% | -96.4% |
| Q4 2020 | $21,462,000 | -35.3% | 224,315 | -23.2% | 0.03% | -47.2% |
| Q3 2020 | $33,150,000 | +482.0% | 292,071 | +407.2% | 0.05% | +430.0% |
| Q2 2020 | $5,696,000 | +89.6% | 57,581 | +23.4% | 0.01% | +42.9% |
| Q1 2020 | $3,004,000 | +78.8% | 46,679 | +65.7% | 0.01% | +133.3% |
| Q4 2019 | $1,680,000 | -45.6% | 28,179 | -46.2% | 0.00% | -50.0% |
| Q3 2019 | $3,091,000 | +8.8% | 52,412 | +19.0% | 0.01% | +20.0% |
| Q2 2019 | $2,842,000 | -32.7% | 44,050 | -33.7% | 0.01% | -37.5% |
| Q1 2019 | $4,220,000 | +39.0% | 66,457 | -16.9% | 0.01% | +14.3% |
| Q4 2018 | $3,037,000 | – | 79,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,022,257 | $60,293,000 | 5.97% |
| APIS CAPITAL ADVISORS, LLC | 50,000 | $2,949,000 | 4.62% |
| SECTORAL ASSET MANAGEMENT INC | 432,815 | $25,527,000 | 4.40% |
| CROWN ADVISORS MANAGEMENT, INC. | 75,000 | $4,424,000 | 2.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 199,410 | $11,761,000 | 2.66% |
| Asymmetry Capital Management, L.P. | 18,995 | $1,120,000 | 2.40% |
| Redmile Group, LLC | 1,160,401 | $68,440,000 | 2.29% |
| FRIESS ASSOCIATES LLC | 501,985 | $29,607,000 | 2.29% |
| Atika Capital Management LLC | 142,000 | $8,375,000 | 1.76% |
| Chicago Capital, LLC | 433,083 | $25,543,000 | 1.71% |